| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/01676830.2017.1280057 |
| P698 | PubMed publication ID | 28296512 |
| P50 | author | Colin M Dayan | Q42533527 |
| Bijay Vaidya | Q46723738 | ||
| John Lazarus | Q55640794 | ||
| P2093 | author name string | A Mitchell | |
| J L Hickey | |||
| G E Rose | |||
| P Foley | |||
| A J Dickinson | |||
| C M Dayan | |||
| P Perros | |||
| J Uddin | |||
| J McLaren | |||
| C J MacEwen | |||
| D G Ezra | |||
| F E Mellington | |||
| Thyroid Eye Disease Amsterdam Declaration Implementation Group (TEAMeD) | |||
| P2860 | cites work | Nursing interventions for smoking cessation | Q24247430 |
| Selenium and the course of mild Graves' orbitopathy | Q28238021 | ||
| Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. | Q34010116 | ||
| Impact of smoking on the response to treatment of thyroid associated ophthalmopathy | Q35591093 | ||
| Assessing quality of life in Australian patients with Graves' ophthalmopathy | Q35591594 | ||
| Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers | Q36568033 | ||
| Planning health care for patients with Graves' orbitopathy. | Q36800348 | ||
| Association between serum selenium level and type 2 diabetes mellitus: a non-linear dose-response meta-analysis of observational studies | Q36865649 | ||
| Treatment options for Graves' orbitopathy | Q37992118 | ||
| Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease. | Q38013212 | ||
| PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012. | Q40962257 | ||
| A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"? | Q41039911 | ||
| Public health relevance of Graves' orbitopathy | Q43428269 | ||
| The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey | Q43579038 | ||
| More on smoking habits and Graves' ophthalmopathy | Q44906164 | ||
| Incidence of hyperthyroidism in Sweden | Q46963719 | ||
| Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. | Q50933902 | ||
| Smoking was associated with poor response to intravenous steroids therapy in Graves' ophthalmopathy. | Q50965755 | ||
| Psychosocial morbidity of Graves' orbitopathy. | Q51925700 | ||
| Smoking and Risk of Graves' Disease | Q54186495 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 159-169 | |
| P577 | publication date | 2017-03-15 | |
| P1433 | published in | Orbit | Q7100035 |
| P1476 | title | Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit | |
| P478 | volume | 36 |
| Q91973798 | A survey of current practices by the British Oculoplastic Surgery Society (BOPSS) and recommendations for delivering a sustainable multidisciplinary approach to thyroid eye disease in the United Kingdom |
| Q101166513 | Clinical features and clinical course of thyroid-associated ophthalmopathy: a case series of 3620 Chinese cases |
| Q91858998 | Current Understanding of the Progression and Management of Thyroid Associated Orbitopathy: A Systematic Review |
Search more.